Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors
Clinical trial NCT01455259 · COMPLETED
Trial details
- NCT number
- NCT01455259
- Sponsor
- Uppsala University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2016-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.